Patents by Inventor Everett Rosey

Everett Rosey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ovo vaccination of campylobacter in avian species
    Publication number: 20070116722
    Abstract: The present invention provides a method of inducing an immune response against Campylobacter in an avian species, especially a domesticated avian species such as chicken, turkey, duck, goose and quail, by administering, in ovo, live cells of Campylobacter.
    Type: Application
    Filed: November 22, 2004
    Publication date: May 24, 2007
    Applicant: PFIZER PRODUCTS INC.
    Inventors: Tonia Agin, Everett Rosey, Frederick Weber
  • Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
    Publication number: 20060233823
    Abstract: The present invention relates to mhp3 nucleic acids and proteins encoded by the foregoing. The present invention further relates to novel apoprotein antigens encoded by mhp3 for use in vaccines to prevent and treat diseases caused by infection with Mycoplasma hyopneumoniae. The invention further relates to methods for the recombinant production of such antigens.
    Type: Application
    Filed: July 3, 2006
    Publication date: October 19, 2006
    Inventors: Kendall King, Rebecca Madura, Everett Rosey
  • Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
    Publication number: 20060159707
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis which encodes an immunogenic FlgE peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. The present invention is also directed to methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms.
    Type: Application
    Filed: March 21, 2006
    Publication date: July 20, 2006
    Inventors: Michael Panaccio, Everett Rosey, Meri Sinistaj, Detlef Hasse, Jim Parsons, Robert Ankenbauer
  • Novel therapeutic compositions for treating infection by Lawsonia spp.
    Publication number: 20050232939
    Abstract: The present invention relates generally to therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism. In particular, the present invention provides a novel gene derived from Lawsonia intracellularis, which encodes an immunogenic polypeptide that is particularly useful as an antigen in a vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts, wherein said polypeptide is selected from the group consisting of flhB, fliR, ntrC, glnH, motA, motB, tlyC, ytfM, and ytfN polypeptides, or a homologue, analogue or derivative of any one or more of said polypeptides.
    Type: Application
    Filed: December 22, 2004
    Publication date: October 20, 2005
    Inventors: Everett Rosey, Kendall King, Robert Good, Richard Strugnell
  • LAWSONIA INTRACELLULARIS PROTEINS, AND RELATED METHODS AND MATERIALS
    Publication number: 20050143561
    Abstract: Isolated polynucleotide molecules contain a nucleotide sequence that encodes a L. intracellularis HtrA, PonA, HypC, LysS, YcfW, ABC1, or Omp100 protein, a substantial portion of the sequences, or a homologous sequence. Related polypeptides, immunogenic compositions and assays are described.
    Type: Application
    Filed: May 30, 2003
    Publication date: June 30, 2005
    Inventor: Everett Rosey
  • Novel proteins from Actinobacillus pleuropneumoniae
    Publication number: 20040198954
    Abstract: The present invention is directed to five novel, low molecular weight proteins from Actinobacillus pleuropneumoniae (APP), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against APP. The present invention is further directed to polynucleotide molecules having nucleotide sequences that encode the proteins, as well as vaccines comprising the proteins or polynucleotide molecules, and methods of making and using the same.
    Type: Application
    Filed: February 3, 2004
    Publication date: October 7, 2004
    Inventors: Robert G. Ankenbauer, Mary Jo Baarsch, Manuel Campos, Robin Keich, Everett Rosey, Brian Suiter, Lynn Warren-Stewart
  • Proteins from actinobacillus pleuropneumoniae
    Patent number: 6713071
    Abstract: The present invention is directed to five novel, low molecular weight proteins from Actinobacillus pleuropneumoniae (APP), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against APP. The present invention is further directed to polynucleotide molecules having nucleotide sequences that encode the proteins, as well as vaccines comprising the proteins or polynucleotide molecules, and methods of making and using the same.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: March 30, 2004
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Robert G. Ankenbauer, Mary Jo Baarsch, Manuel Campos, Robin Keich, Everett Rosey, Brian Suiter, Lynn Warren-Stewart